ABSTRACT A total of 482 percutaneous transluminal angioplasties (PTAs) 
THE FIRST DESCRIPTION and report on the clinical application of transluminal angioplasty by Dotter and Judkins' appeared in Circulation 20 years ago, but only after technical improvement in the original Dotter procedure was made by Grfintzig2 did the method gain popularity. He developed a double-lumen catheter with a preshaped balloon that could be used in the treatment of arteries of the lower limbs2' and that, a few years later, was modified for use in the coronary4 and renal arteries.5 6 Percutaneous transluminal angioplasty (PTA) could indeed represent an attractive alternative to conservative therapy or vascular surgery.
However, as pointed out in recent articles on PTA,7`' more studies on the long-term success and complication rate are needed to establish conclusively the place of the procedure in the treatment of patients with occlusive disease of the peripheral arteries.
Here we present a 5 year follow-up in 411 patients who underwent PTA of the arteries of the lower limbs and discuss the influence of different clinical and angiographic factors on early and late prognosis.
Patients and methods 
Results
Patency rates. A total of 134 iliac and 251 femoral PTAs were initially successful, corresponding to early patency rates of 95% for the iliac and of 87% for the femoral arteries, respectively, as shown in figure 1. Patency rates 1 year after attempted PTA were 86% for the iliac and 61% for the femoral procedures, whereas the 5 year patency rates were 83% and 58%, respectively. Patency rates 5 years after PTA as percentages of successful rather than of attempted procedures were 87% for iliac and 67% for femoral PTAs. The patency rates did not change substantially after the first year of follow-up. The mean follow-up time was 
Discussion
Our results indicating a reasonably good long-term prognosis after PTA of the arteries of the lower limbs in patients with arterial occlusive disease are in accordance with previous reports.2 9, l3-25 From a clinical point of view a remarkable improvement in the symptoms occurred: before femoral PTA approximately two-thirds of the patients had claudication and onethird had pain at rest, whereas 2 years after PTA twothirds of the patients had no symptoms. These clinical results were corroborated by the significant improvement of the arterial pressures in the ankle during the follow-up period.2 7 We found recently that the armankle APs correlate well with the angiographically detected changes in the arteries and represent a reliable long-term follow-up criterium after PTA.1'
The 5 year patency rates of 83% after iliac PTA and 58% after femoropopliteal PTA are slightly lower than those reported after aortoiliac surgery (72% to 92%)27. 25 and femoropopliteal bypass surgery (59% to 78%),29-34 but slightly above the patency rate after thromboendarterectomy. 35 However, in our analysis the technical failures were regarded as early losses of patency whereas in general only successful operations are evaluated in the surgical literature. Excluding technical failures our patency rate 5 years after PTA would Severe complications of these procedures were rare when compared with vascular surgery-28: no fatal complications and no amputations were the direct result of PTA. With the back-up of a vascular surgeon PTA thus proved safe, and even if effects of PTA procedures are not as long lasting as those of surgery, the consequences of failure are also not as deleterious. The danger of relapse seems to be particularly high during the first 12 months after angioplasty. However, in the majority of patients with reocclusions, PTA could be repeated successfully, and in those in whom angioplasty was no longer feasible, vascular surgery could still be performed. PTA is therefore not a competitive but a complementary procedure to vascular surgery. Secondary prevention should probably be kept in mind in the early vulnerable phase after PTA. However, no definite statement on this controversial subject3 21 . 25 36 can be made on the basis of the present report, and an adequate study is still necessary.
The fact that angioplasty does not require surgery and is performed in patients under local anesthesia obviously significantly reduces risk of morbidity and duration and cost of hospitalization, as shown in a recent report.8 Patients with isolated stenosis in whom the decision to operate seems premature because of relatively mild symptoms seem to be ideal candidates for PTA. This approach is justified by our previous observation that many symptomatic stenoses of the superficial femoral arteries progress rapidly to total occlusions.38 PTA may also represent a therapeutic chance for those critically ill patients in whom surgical intervention is hazardous. For patients in whom PTA or surgery can be considered, the present analysis may help to identify the appropriate candidates for PTA. Considering the favorable 5 year success rate and safety and economy, PTA of the arteries of the lower limbs may be regarded today as a valid modality in the treatment of occlusive disease of the peripheral arteries.
